JP MORGAN/PUT/BECTON DICKINSON AND CO./220/0.1/19.07.24 Stock

Warrant

DE000JT0YSN2

Real-time Bid/Ask 13:29:21 2024-06-27 EDT
0.26 EUR / 0.29 EUR +71.88% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./220/0.1/19.07.24
Current month-76.81%
1 month-75.00%
Date Price Change
24-06-27 0.22 +37.50%
24-06-25 0.16 +33.33%
24-06-24 0.12 -20.00%
24-06-21 0.15 -37.50%
24-06-20 0.24 -11.11%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 08:46 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JT0YSN
ISINDE000JT0YSN2
Date issued 2024-05-24
Strike 220 $
Maturity 2024-07-19 (22 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.78
Lowest since issue 0.12
Spread 0.03
Spread %9.68%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
231.6 USD
Average target price
279.2 USD
Spread / Average Target
+20.54%
Consensus